Opus Genetics Inc.
IRD | NASDAQ
$3.67
+$0.02 (+0.55%)
At close: Oct 30, 2026, 4:00 PM ET
$3.77
+$0.10 (+2.72%)
Pre-market:
Nov 2, 2026, 5:44 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 14.2M | 10.99M | 19.05M | 39.85M | 589K | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 14.2M | 10.99M | 19.05M | 39.85M | 589K | n/a |
Operating Income | -38.6M | -62.07M | -10.56M | 18.23M | -22.71M | -19.97M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -49.59M | -57.53M | -9.97M | 18.2M | -56.69M | -24.62M |
Net Income | -49.59M | -57.53M | -9.99M | 17.89M | -56.69M | -24.62M |
Selling & General & Admin | 21.98M | 18.22M | 11.96M | 7.27M | 8.12M | 2.82M |
Research & Development | 30.81M | 26.85M | 17.65M | 14.36M | 15.17M | 6.65M |
Other Expenses | n/a | 28M | n/a | n/a | n/a | 10.5M |
Operating Expenses | 52.8M | 73.07M | 29.61M | 21.62M | 23.29M | 19.97M |
Interest Expense | 1.47M | n/a | 1.33M | 9K | 2K | 6.85M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 52.8M | 73.07M | 29.61M | 21.62M | 23.29M | 19.97M |
Income Tax Expense | n/a | n/a | 12K | 315K | n/a | n/a |
Shares Outstanding (Basic) | 622.22M | 26.72M | 21.59M | 19.93M | 14.85M | 4.66M |
Shares Outstanding (Diluted) | 622.22M | 26.72M | 21.59M | 20.6M | 14.85M | 4.66M |
EPS (Basic) | -0.80 | -2.15 | -0.46 | 0.90 | -3.82 | -5.28 |
EPS (Diluted) | -0.80 | -2.15 | -0.46 | 0.87 | -3.82 | -5.28 |
EBITDA | -48.07M | -57.52M | -9.97M | 18.22M | -56.69M | -17.77M |
EBIT | -48.13M | -57.53M | -9.97M | 18.21M | -56.69M | -17.77M |
Depreciation & Amortization | 53K | 10K | 6K | 4K | 4K | 8K |
Add to Watchlist
Select watchlists to add or remove IRD